Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Pharmaceutical agent comprising anti-BMP9 antibody as active ingredient for treatment of anemia such as renal anemia and cancer anemia

Pharmaceutical agent comprising anti-BMP9 antibody as active ingredient for treatment of anemia such as renal anemia and cancer anemia

US Patent 8969040 · Granted Mar 3, 2015

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

FN14 antibodies and uses thereof2025
Article transfer facility2024
Joined metal member and manufacturing method therefor2023
Rare earth magnet precursor or rare earth magnet molded body having roughened st2023
Antibody with non-natural amino acid introduced therein2023
Subsurface soil purification method2023
Ground injection agent concentration estimation method2022
Subsurface soil purification method2021
Contaminated soil purification method2021
Antibody with non-natural amino acid introduced therein2021
Anti human Gas6 monoclonal antibody2020
Anti human Gas6 monoclonal antibody2020